NMR spectroscopy in structure-based drug design

Current Opinion in Biotechnology

Volumn 10, Issue 1, 1999, Pages 42-47

  Roberts, Gordon Ck ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

BINDING SITE; DRUG DESIGN; LIGAND BINDING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

EID: 0032899363     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(99)80008-1     Document Type: Article

References (73)

1. Amzel LM Structure-based drug design. Curr Opin Biotechnol. 9:1998;366-369.
2. Salemme FR, Spurlino J, Bone R Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery. Structure. 5:1997;319-324.
3. Stockman BJ NMR spectroscopy as a tool for structure-based drug design. Prog NMR Spectrosc. 33:1998;109-151. A valuable current review of the field describing the basic techniques used to study protein-ligand complexes and their application to a number of specific drug-target systems, including immunophilins, HIV protease, dihydrofolate reductase, matrix metalloproteinases and glycoprotein IIb-IIIa.
4. Gargaro AR, Soteriou A, Frenkiel TA, Bauer CJ, Birdsall B, Polshakov VI, Barsukov IL, Roberts GCK, Feeney J The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate. J Mol Biol. 277:1998;119-134.
5. Wlodawer A, Vondrasek J Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. Annu Rev Biophys Biomol Struct. 27:1998;249-284. An informative and critical review of the contributions of crystallography and NMR to the design of HIV protease inhibitors, including several case studies.
6. Yamazaki T, Hinck AP, Wang Y, Nicholson LK, Torchia DA, Wingfield P, Stahl SJ, Kaufman JD, Chang CH, Domaille PJ, Lam PYS Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance. Protein Sci. 5:1996;495-506.
7. Chen H, Liu X, Patel DJ DNA bending and unwinding associated with actinomycin D antibiotics bound to partially overlapping sites on DNA. J Mol Biol. 258:1996;457-479.
8. ••].
9. ••] describe the structures of complexes of two enediyne antitumour antibiotics with cognate oligonucleotides. These structures provide explanations for the observed sequence-specificity of the two compounds, and show how the binding positions the pro-radical centres appropriately for double-strand cleavage.
10. ••].
11. Kay LE, Gardner KH Solution NMR spectroscopy beyond 25 kDa. Curr Opin Struct Biol. 7:1997;722-731.
12. Tjandra N, Garrett DS, Gronenborn AM, Bax A, Clore GM Defining long range order in NMR structure determination from the dependence of heteronuclear relaxation times on rotational diffusion anisotropy. Nat Struct Biol. 4:1997;443-449.
13. Tjandra N, Bax A Direct measurement of distances and angles in biomolecules by NMR in a dilute liquid crystalline medium. Science. 278:1997;1111-1114. Describes the use of residual dipolar couplings in proteins partly oriented in a dilute solution of phospholipid bicelles to obtain structural information. This is an important addition to the available methods for obtaining structural information from NMR.
14. 1H cross-peak in, for example, an HMQC spectrum. This paper describes a method for selecting only the narrowest component, making it possible to obtain sharp lines from large proteins, and thus promising to extend substantially the upper size limit for studying proteins by NMR.
15. Palmer AG III Probing molecular motion by NMR. Curr Opin Struct Biol. 7:1997;732-737. A valuable review describing recent developments in NMR methods for studying internal motion in proteins.
16. Jardetzky O Protein dynamics and conformational transitions in allosteric proteins. Prog Biophys Mol Biol. 65:1996;171-218.
17. Abseher A, Horstink L, Hilbers CW, Nilges M Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap. Proteins Struct Func Genet. 31:1998;370-382. An informative comparison of the structural ensembles obtained by NMR and by molecular dynamics simulations for two very different systems. The rather surprising conclusion is that the large-scale correlated motions indicated by the two very different methods are quite similar. This lends support to the idea that less well-defined regions of solution structures determined by NMR are likely to be mobile. The comparison also leads to a proposal for an improved selection criterion for inclusion of structures in the 'NMR ensemble' to ensure that amplitudes of motion are better represented.
18. Akke M, Liu J, Cavanagh J, Erickson HP, Palmer AG III Pervasive conformational fluctuations on microsecond timescales in a fibronectin type III domain. Nat Struct Biol. 5:1998;55-59.
19. Nieto PM, Birdsall B, Morgan WD, Frenkiel TA, Gargaro AR, Feeney J Correlated bond rotations in interactions of arginine residues with ligand carboxylate groups in protein ligand complexes. FEBS Lett. 405:1997;16-20.
20. Ottiger M, Zerbe O, Güntert P, Wüthrich K The NMR solution conformation of unligated human cyclophilin A. J Mol Biol. 272:1997;64-81.
21. ••].
22. •], provides a detailed analysis of the mobility of a discrete region in intestinal fatty-acid binding protein and the way in which this changes on fatty acid binding. It is proposed that this mobility is required for access of the fatty acid to its binding site.
23. ••].
24. 15N relaxation with monomer/dimer equilibration. J Mol Biol. 266:1997;173-194.
25. 2 and NOE) relaxation measurements.
26. 15N relaxation studies show that many residues involved in peptide binding are motionally restricted in the free protein; others become more restricted on peptide binding - including some residues that do not contact the ligand directly.
27. 13C chemical shifts. J Mol Biol. 267:1997;933-952. The NMR structure of this peptide-SH3 domain complex shows that the peptide residues in the first and second subsites are well-ordered, but a range of evidence is presented for mobility in the third subsite. The possibility of fluctuating hydrogen bonding interactions is discussed in which a donor on the peptide or protein can interact with alternative acceptors on the other partner.
28. 2H relaxation measurements on methyl groups of two SH2 domains were used to probe changes in their dynamics on binding peptides. Both increases and decreases in mobility were observed, and the two domains showed different patterns of behaviour. The paper contains a valuable discussion of the relationships between dynamics, binding thermodynamics and specificity.
29. 15N NMR relaxation studies of free and inhibitor-bound 4-oxalocrotonate tautomerase: backbone dynamics and entropy changes of an enzyme upon inhibitor binding. Biochemistry. 35:1996;16036-16047.
30. 2+ binding by calbindin D9k. J Am Chem Soc. 115:1993;9832-9833.
31. Yang D, Kay LE Contributions to conformational entropy arising from bond vector fluctuations measured from NMR-derived order parameters: application to protein folding. J Mol Biol. 263:1996;369-382.
32. Feeney J NMR studies of interactions of ligands with dihydrofolate reductase. Biochem Pharmacol. 40:1990;141-152.
33. Feeney J NMR studies of ligand binding to dihydrofolate reductase and their applications in drug design. Craik D NMR and Drug Design. 1996;CRC Press, New York.
34. 13C-Asp]-labelled enzyme was used to study the ionisation state of the active-site aspartic acid.
35. Ross A, Slazmann M, Senn H Fast-HMQC using Ernst angle pulses: an efficient tool for screening of ligand binding to target proteins. J Biomol NMR. 10:1997;389-396.
36. Tilley JW, Chen L, Fry DC, Emerson SD, Powers GD, Biondi D, Varnell T, Trilles R, Guthrie R, Mennona Fet al. Identification of a small molecule inhibitor of the IL-2/IL-2Rα receptor interaction which binds to IL-2. J Am Chem Soc. 119:1997;7589-7590.
37. Morken JP, Kapoor TM, Feng S, Shirai F, Schreiber SL Exploring the leucine-proline binding pocket of the Src SH3 domain using structure-based, split-pool synthesis and affinity-based selection. J Am Chem Soc. 120:1998;30-36.
38. + binding site on the MurB enzyme by NMR. Nat Struct Biol. 3:1996;995-997.
39. Kleerekoper Q, Liu W, Choi D, Putkey JA Identification of binding sites for beperidil and trifluoperazine on cardiac troponin C. J Biol Chem. 273:1998;8153-8160.
40. 1H NMR spectroscopy - combined use with isotope labeling for studies of macromolecular conformation and intermolecular interactions. Q Rev Biophys. 23:1990;39-96.
41. Zwahlen C, Legault P, Vincent SJF, Greenblatt J, Konrat R, Kay LE Methods for the measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage I N-peptide/box B RNA complex. J Am Chem Soc. 119:1997;6711-6721.
42. Martorell G, Gradwell MJ, Birdsall B, Bauer CJ, Frenkiel TA, Cheung HTA, Polshakiv VI, Kuyper L, Feeney J Solution structure of bound trimethoprim in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry. 33:1994;12416-12426.
43. Morgan WD, Birdsall B, Polshakov VI, Sali D, Kompis I, Feeney J Solution structure of a brodimoprim analog in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry. 34:1995;11690-11702.
44. Johnson J, Meiering EM, Wright JE, Pardo J, Rosowsky A, Wagner G NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase. Biochemistry. 36:1997;4399-4411.
45. Gonnella NC, Li YC, Zhang XL, Paris CG Bioactive conformation of a potent stromelysin inhibitor determined by X-nucleus filtered and multidimensional NMR spectroscopy. Bioorg Med Chem. 5:1997;2193-2201.
46. Gradwell MJ, Feeney J Validation of the use of intermolecular NOE constraints for obtaining docked structures of protein-ligand complexes. J Biomol NMR. 7:1996;48-58.
47. Modi S, Paine MJI, Sutcliffe MJ, Lian L-Y, Primrose WU, Wolf CR, Roberts GCK A model for human cytochrome P450 2D6 based on homology modelling and NMR studies of substrate binding. Biochemistry. 35:1996;4540-4550.
48. Modi S, Gilham DE, Sutcliffe MJ, Lian L-Y, Primrose WU, Wolf CR, Roberts GCK 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase. Biochemistry. 36:1997;4461-4470. Paramagnetic relaxation experiments (see [47]) are used to measure distances from the haem iron to protons of the substrate bound to P450 2D6. These experiments show that, in the presence of P450 reductase but not in its absence, the substrate can bind in two different orientations, which correspond to the two products formed. This illustrates the usefulness of the paramagnetic relaxation approach in studying the specificity of P450s.
49. Modi S, Sutcliffe MJ, Primrose WU, Lian L-Y, Roberts GCK The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction. Nat Struct Biol. 3:1996;414-417.
50. Oliver CF, Modi S, Sutcliffe MJ, Primrose WU, Lian L-Y, Roberts GCK A single-residue mutation in cytochrome P450 changes the substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. Biochemistry. 36:1997;1567-1572.
51. Poli-Scaife S, Attias R, Dansette PM, Mansuy D The substrate binding site of human liver cytochrome P450 2C9: an NMR study. Biochemistry. 36:1997;12672-12682. Paramagnetic relaxation experiments are used to position several substrates relative to the haem iron of P450 2C9, and to identify features of the active site (e.g. the location of a putative positive charge) from the superposition of the substrates.
52. Albrand JP, Birdsall B, Feeney J, Roberts CK, Burgen ASV The use of transferred nuclear Overhauser effects in the study of the conformation of small molecules bound to proteins. Int J Biol Macromol. 1:1979;37-41.
53. Clore GM, Gronenborn AM Theory and application of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J Magn Reson. 48:1982;402-417.
54. Campbell AP, Sykes BD The two-dimensional transferred nuclear Overhauser effect - theory and practice. Annu Rev Biophys Biomol Struct. 22:1993;99-122.
55. Ni F Recent advances in transferred NOE methods. Prog NMR Spectrosc. 26:1994;517-605.
56. Bertho G, Gharbi-Benarous J, Delaforge M, Girault JP Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations. Bioorg Med Chem. 6:1998;209-221.
57. Arepalli SR, Glaudemans CPJ, Daves GD, Kovac P, Bax A Identification of protein-mediated indirect NOE effects in a disaccharide-Fab′ complex by transferred ROESY. J Magn Reson B. 106:1995;195-198.
58. Barsukov IL, Lian L-Y, Ellis J, Sze K-H, Shaw WV, Roberts GCK The conformation of coenzyme A bound to chloramphenicol acetyltransferase determined by transferred NOE experiments. J Mol Biol. 262:1996;543-558.
59. Polenova T, Iwashita T, Palmer AG III, McDermott AE Conformation of the trypanocidal pharmaceutical in its free and bound forms: transferred nuclear Overhauser studies. Biochemistry. 36:1997;14202-14217.
60. Massefski W, Redfield AG Elimination of multiple-step spin diffusion effects in two-dimensional NOE spectroscopy of nucleic acids. J Magn Reson. 78:1988;150-155.
61. Zolnai Z, Juranic N, Markley JL, Macura S Magnetization exchange network editing - mathematical principles and experimental demonstration. Chem Phys. 200:1995;161-179.
62. Juranic N, Zolnai Z, Macura S Identification of spin diffusion pathways in proteins by isotope-assisted NMR cross-relaxation network editing. J Biomol NMR. 9:1997;317-322.
63. + was similar to that seen in the crystal, but that about the nicotinamide glycosidic bond was not, and the coexistence of two conformations about this bond in the complex is suggested.
64. Cox JR, Serpersu EH Biologically important conformations of aminoglycoside antibiotics bound to an aminoglycoside 3′-phosphotransferase as determined by transferred nuclear Overhauser effect spectroscopy. Biochemistry. 36:1997;2353-2359.
65. Nicotra M, Paci M, Sette M, Oakley AJ, Parker MW, Lo Bello M, Caccuri AM, Federici G, Ricci G Solution structure of glutathione bound to human glutathione transferase P1-1: comparison of NMR measurements with the crystal structure. Biochemistry. 37:1998;3020-3027. Transferred NOE experiments lead to a conformation of bound glutathione that has a similar backbone conformation but sidechain conformations that differ from those seen in the crystal. The origins of this difference are discussed in the light of docking calculations and kinetic experiments; it is concluded that the NMR structure may correspond to that of a 'pre-complex' (see also [58]).
66. Espinosa JF, Montero E, Vian A, García JL, Dietrich H, Schmidt RR, Martín-Lomas M, Imberty A, Cañada FJ, Jiménez-Barbero J Escherichia coli β-galactosidase recognizes a high-energy conformation of C-lactose, a non-hydrolyzable substrate analogue. NMR and modelling studies of the molecular complex. J Am Chem Soc. 120:1998;1309-1318. Transferred NOE experiments indicate that C-lactose (in which the glycosidic oxygen of lactose is replaced by a methylene group) bound to β-galactosidase adopts a conformation which is only slightly populated (~5%) in the free ligand.
67. Montero M, Vallmitjana M, Pérez-Pons JA, Querol E, Jiménez-Barbero J, Cañada FJ NMR studies of the conformation of thiocellobiose bound to a β-glucosidase from Streptomyces sp. FEBS Lett. 421:1998;243-248.
68. x tetrasaccharide, the sialyl residue is attached via a flexible glycosidic linkage to a rigid branched trisaccharide. A careful quantitative analysis of transferred NOE experiments shows that different conformers of the tetrasaccharide are recognised by E- and P-selectin on the one hand and L-selectin on the other.
69. LaPlante SR, Aubry N, Bonneau PR, Cameron DR, Lagacé L, Massariol M-J, Montpetit H, Plouffe C, Kawai SH, Fulton BDet al. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation. Biochemistry. 37:1998;9793-9801.
70. Fraternali F, Do Q-T, Doan B-T, Atkinson RA, Palmas P, Sklenar V, Safar P, Wildgoose P, Strop P, Saudek V Mapping the active site of factor Xa by selective inhibitors: and NMR and MD study. Proteins Struct Func Genet. 30:1998;264-274. Two peptide inhibitors of factor Xa, obtained by library screening, were studied by transferred NOE experiments. Structures were calculated both for the peptides in isolation and in the binding site (see also [58]), systematically exploring possible orientations in the site. The model of the complex obtained, suggesting that the inhibitors bind differently from the substrate, made it possible to explain the specificity of the inhibitors.
71. Eisenmesser EZ, Post CB Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 37:1998;867-877.
72. Gizachew D, Moffett DB, Busse SC, Westler WM, Dratz EA, Teintze M NMR studies on the conformation of the CD4 36-59 peptide bound to HIV gp120. Biochemistry. 37:1998;10616-10625. Transferred NOE experiments, including identification of spin diffusion effects, led to a well-defined backbone conformation for residues 42-49 of the peptide corresponding to CD4 residues 36-59 when bound to HIV-1 gp120. The calculated conformation differed from that seen in either of two crystal structures of CD4, suggesting a change in conformation on binding.
73. •] show the value of transferred NOE experiments in giving access to the peptide conformation in the bound state, as a model for the design of peptidomimetic drugs.